Protein-Prebiotic Wellbeing Study

March 31, 2025 updated by: Arizona State University

An Exploratory Study on the Effect of Fermented Dairy Protein With Prebiotic Fiber in Athletes

Healthy participants with self-reported GI complaints will consume the protein supplement that they normally use for recovery purposes after exercise during a 3-week baseline period, followed by a 3-week intervention period in which they maintain usage of their product, but replace a part of this product with a fermented dairy protein with prebiotic fiber. In addition, a group of healthy participants without self-reported GI complaints will serve as a reference group by consuming the protein supplement that they normally use for recovery purposes after exercise during a 3-week period.

Study Overview

Detailed Description

A substantial number of athletes suffer from gastro-intestinal problems, which may impair performance and/or subsequent recovery. Also, gut barrier integrity is impaired with high-intensity training. Emerging studies are showing a positive correlation between the gut microbiome and muscle function, athletic performance, body composition, and natural energy levels. This study will perform an exploratory analysis of the well-being and digestive health of well-trained athletes, and assess the potential effect of fermented dairy protein with prebiotic fiber on these parameters.

Question 1: Does the 3-week supplementation of a fermented dairy protein with prebiotic fiber affect the self-reported digestive comfort compared to a 3-week baseline period? And additionally, will the quality of life (self-reported general well-being and states of mood) change with the use of this type of product?

Question 2: Does the 3-week supplementation of a fermented dairy protein with prebiotic fiber show an alteration in gut microbiota in comparison to a 3-week baseline period, while dietary intake remains unaffected?

Question 3: How is the 3-week supplementation of a fermented dairy protein with prebiotic fiber experienced by the participants (taste and concept liking)?

Question 4: Is there a difference in baseline gut microbiota between athletes with and athletes without self-reported GI complaints.

Study Type

Interventional

Enrollment (Actual)

98

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Phoenix, Arizona, United States, 85004
        • Arizona State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy subjects living in Arizona in the USA
  • Women/Men aged between 18-35 years
  • Serious athletes (exercise at least 3 x per week)
  • With or without GI tract issues due to sport or protein/diet intake
  • 18.5 ≤ BMI ≤ 40 kg/m2
  • No physical limitations (i.e. able to perform all activities associated with daily living in an independent manner).
  • Use of a protein supplement or sports food after at least one training per day 3 x per week
  • Willing to slightly increase their protein supplement intake during the intervention phase for 21 consecutive days
  • Stable weight during the last 4 weeks, without a focus on body weight reduction through limiting caloric intake
  • Written informed consent

Exclusion Criteria:

  • Daily use of (sport) supplements containing probiotics and/or prebiotics
  • Smoking
  • Self-reported cow's milk protein allergy
  • Clinical lactose intolerance
  • Clinical milk protein allergy
  • House dust mite allergy
  • Diagnosed GI tract disorders or diseases
  • Musculoskeletal disorders
  • Metabolic disorders (such as diabetes)
  • Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications).
  • Chronic use of gastric acid-suppressing medication or anti-coagulants
  • Use of antibiotics or anti-inflammatory medication the past 2 weeks
  • Blood donation in the past 2 months
  • Pregnant/lactating women
  • Athletes should not aim to lose body weight by reducing energy intake during the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Single group
During a 3-week baseline period, participants with self-reported GI complaints consume their own protein supplement that they use for recovery purposes after exercise, followed by a 3-week intervention period in which they maintain usage of their own product, but replace a part of this product with a fermented dairy protein with prebiotic fiber. An additional reference group of athletes without self-reported GI complaints will also be followed during a 3-week period in which they consume their own protein supplement that they use for recovery purposes after exercise.
During the intervention period, the participant will consume a new product and will reduce the amount of protein in their normal diet reflecting the protein content of the new product.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in self-reported digestive comfort
Time Frame: Baseline (day 0), after 21 days and after 42 days.
Gastrointestinal Symptoms Rating Scores (GSRS-score: Average of all 5 sub-scores)
Baseline (day 0), after 21 days and after 42 days.
Change in daily self-reported digestive comfort
Time Frame: Study period covering day 1 to day 21 compared to day 22-42.
Daily variation of GI complaints (averaged itemized score 1-10)
Study period covering day 1 to day 21 compared to day 22-42.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in self-reported general wellbeing - Physical Health
Time Frame: Baseline (day 0), after 21 days and after 42 days.
Reported as physical wellbeing (Physical Health Questionnaire, PHX - average score 1-7 based on 14 items)
Baseline (day 0), after 21 days and after 42 days.
Change in self-reported general wellbeing - Psychological Distress
Time Frame: Baseline (day 0), after 21 days and after 42 days.
Reported as psychological distress (mental distress, K6 scale - average score 0-24).
Baseline (day 0), after 21 days and after 42 days.
Change in participants microbiota composition of fecal samples
Time Frame: Baseline (day 0), after 21 days and after 42 days.
16s microbial profiling
Baseline (day 0), after 21 days and after 42 days.
Change in dietary intake
Time Frame: Baseline (day 0), after 21 days and after 42 days.
24-hour dietary recalls (food group intake, energy and macro- and micronutrient)
Baseline (day 0), after 21 days and after 42 days.
Chane in self-reported states of mood
Time Frame: Baseline (day 0), after 21 days and after 42 days.
Profile of Mood States (POMS)
Baseline (day 0), after 21 days and after 42 days.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in food composition and diet quality
Time Frame: Baseline (day 0), after 21 days and after 42 days.
Rapid eating assessment in participants (REAP)
Baseline (day 0), after 21 days and after 42 days.
Change in product experience
Time Frame: Baseline (day 0), days 22, 23, 29, 36, 43.
Question about product experience (taste and concept liking)
Baseline (day 0), days 22, 23, 29, 36, 43.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Floris Wardenaar, PhD, Arizona State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 26, 2022

Primary Completion (Actual)

July 11, 2022

Study Completion (Actual)

July 11, 2022

Study Registration Dates

First Submitted

February 14, 2022

First Submitted That Met QC Criteria

March 21, 2022

First Posted (Actual)

March 31, 2022

Study Record Updates

Last Update Posted (Actual)

April 3, 2025

Last Update Submitted That Met QC Criteria

March 31, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on fermented dairy protein with prebiotic fiber

Subscribe